The reiteration of a Buy rating and a high price target by a reputable analyst firm like HC Wainwright & Co. typically instills confidence among investors, potentially leading to a positive short-term impact on the stock price. The firm's continued endorsement suggests a strong belief in United Therapeutics' fundamentals and growth trajectory, which could influence investor sentiment positively.